These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. HIV-occlusive vascular disease. van Marle J, Mistry PP, Botes K. S Afr J Surg; 2009 May; 47(2):36-42. PubMed ID: 19626778 [Abstract] [Full Text] [Related]
47. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study. Othman M, Kawar B, El Nahas AM. Nephron Clin Pract; 2009 May; 113(1):c16-23. PubMed ID: 19590231 [Abstract] [Full Text] [Related]
48. Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial. Shah SJ, Blair JE, Filippatos GS, Macarie C, Ruzyllo W, Korewicki J, Bubenek-Turconi SI, Ceracchi M, Bianchetti M, Carminati P, Kremastinos D, Grzybowski J, Valentini G, Sabbah HN, Gheorghiade M, HORIZON-HF Investigators. Am Heart J; 2009 Jun; 157(6):1035-41. PubMed ID: 19464414 [Abstract] [Full Text] [Related]
49. [State of microcirculation in patients with atherosclerotic-aetiology stage IV chronic arterial insufficiency of lower limbs]. Lisin SV, Chadaev AP, Krupatkin AI, Rogov KA, Markov AV, Kozhemiakin SA. Angiol Sosud Khir; 2008 Jun; 14(1):21-8. PubMed ID: 19156026 [Abstract] [Full Text] [Related]
51. [Oscillographic control of the test of reactive hyperemia in healthy subjects & in patients with arterial diseases]. GARELLO L. Arch Maragliano Patol Clin; 1958 Jun; 14(3):695-705. PubMed ID: 13572181 [No Abstract] [Full Text] [Related]
52. Australian Clinical Toxicology Investigators Collaboration randomized trial of different loading infusion rates of N-acetylcysteine. Gawarammana IB, Greene SL, Dargan PI, Jones AL. Ann Emerg Med; 2006 Jan; 47(1):124; author reply 124-5. PubMed ID: 16387234 [No Abstract] [Full Text] [Related]
53. Intravenous loading infusion rates of N-acetylcysteine. Manini AF, Snider C. Ann Emerg Med; 2006 Jan; 47(1):123-4; author reply 124-5. PubMed ID: 16387232 [No Abstract] [Full Text] [Related]
54. Commentary. Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Bekelis K, Labropoulos N. Perspect Vasc Surg Endovasc Ther; 2008 Jun; 20(2):224-6. PubMed ID: 18644817 [No Abstract] [Full Text] [Related]
55. Secondary prevention in patients with peripheral arterial disease: are we letting our patients down? Vohra RS, Gough MJ, Homer-Vanniasinkam S, Mavor AI, Howell S. Eur J Vasc Endovasc Surg; 2007 Feb; 33(2):190-1. PubMed ID: 17164086 [No Abstract] [Full Text] [Related]
59. Influence of peripheral arterial disease on the initial changes in digital volume during reactive hyperemia. WINSOR T. Angiology; 1951 Aug; 2(4):243-55. PubMed ID: 14857365 [No Abstract] [Full Text] [Related]